Patents by Inventor Songon An

Songon An has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of identifying a compound which affects the multienzyme metabolic assembly of glucose metabolism and its association with cell cycle progression in cancer cells
    Patent number: 11474097
    Abstract: A cell-based quantitative high-throughput screening assay to monitor the formation of PFK1-mEGFP clusters by the action of small molecules to identify small molecules that promote intracellular PFK1 clustering in a cell cycle-dependent manner and may be used to treat cancer.
    Type: Grant
    Filed: June 26, 2019
    Date of Patent: October 18, 2022
    Assignees: UNIVERSITY OF MARYLAND, BALTIMORE COUNTY, NATIONAL INSTITUTES OF HEALTH
    Inventors: Songon An, Danielle L. Schmitt, James Inglese, Patricia Dranchak
  • METHOD OF IDENTIFYING A COMPOUND WHICH AFFECTS THE MULTIENZYME METABOLIC ASSEMBLY OF GLUCOSE METABOLISM AND ITS ASSOCIATION WITH CELL CYCLE PROGRESSION IN CANCER CELLS
    Publication number: 20190391135
    Abstract: A cell-based quantitative high-throughput screening assay to monitor the formation of PFK1-mEGFP clusters by the action of small molecules to identify small molecules that promote intracellular PFK1 clustering in a cell cycle-dependent manner and may be used to treat cancer.
    Type: Application
    Filed: June 26, 2019
    Publication date: December 26, 2019
    Inventors: Songon AN, Danielle L. SCHMITT, James INGLESE, Patricia DRANCHAK
  • METHODS TO IDENTIFY TARGETS AND MOLECULES REGULATING PURINOSOMES AND THEIR USES
    Publication number: 20120190620
    Abstract: The present invention discloses methods to identify targets, pathways and molecules regulating purinosomes and their uses for treating pathophysiological disorders associated with purinosomes. Disclosed are methods related to both label-free cellular assays and fluorescence imaging to confirm the regulatory roles of various targets and molecules in purinosome dynamics. Disclosed are methods to classify molecules and the uses of these molecules for different indications. Specifically, the purinosome-disrupting molecules can be used for improved prevention and treatment of cancer development.
    Type: Application
    Filed: July 18, 2011
    Publication date: July 26, 2012
    Inventors: Stephen Benkovic, Ye Fang, Songon An, Florence Verrier